119th Congress•Senate
S. 4327
CommitteeA bill to require regulatory review of pharmaceutical products from Chinese entities, and for other purposes.
Latest action
2026-04-16
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Key actions
- Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- Introduced in Senate
Bill text versions
No text versions found.
Related bills
No related bills listed.